Diagnosis and Treatment of Malignant Pheochromocytoma

作者: Mitsuhide Naruse , Akiyo Tanabe , Mika Tsuiki , Kazutaka Nanba , Kanako Nakao

DOI: 10.2169/NAIKA.101.2330

关键词:

摘要:

参考文章(19)
Kawaoi A, Katoh R, Kobayashi M, Obara T, Nagura S, Omata K, Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas. Modern Pathology. ,vol. 12, pp. 1107- ,(1999)
Hartmut P.H. Neumann, Birke Bausch, Sarah R. McWhinney, Bernhard U. Bender, Oliver Gimm, Gerlind Franke, Joerg Schipper, Joachim Klisch, Carsten Altehoefer, Klaus Zerres, Andrzej Januszewicz, Wendy M. Smith, Robin Munk, Tanja Manz, Sven Glaesker, Thomas W. Apel, Markus Treier, Martin Reineke, Martin K. Walz, Cuong Hoang-Vu, Michael Brauckhoff, Andreas Klein-Franke, Peter Klose, Heinrich Schmidt, Margarete Maier-Woelfle, Mariola Peçzkowska, Cesary Szmigielski, Charis Eng, Germ-line mutations in nonsyndromic pheochromocytoma. The New England Journal of Medicine. ,vol. 346, pp. 1459- 1466 ,(2002) , 10.1056/NEJMOA020152
Camilo Jimenez, Maria E. Cabanillas, Libero Santarpia, Eric Jonasch, Karen L. Kyle, Elizabeth A. Lano, Surena F. Matin, Rodolfo F. Nunez, Nancy D. Perrier, Alexandria Phan, Thereasa A. Rich, Beejal Shah, Michelle D. Williams, Steven G. Waguespack, Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease : Targeting Angiogenic Factors in Pheochromocytoma and Other von Hippel-Lindau Disease-Related Tumors The Journal of Clinical Endocrinology and Metabolism. ,vol. 94, pp. 386- 391 ,(2009) , 10.1210/JC.2008-1972
KAISA SALMENKIVI, PAIVI HEIKKIL, JIANQI LIU, CAJ HAGLUND, JOHANNA AROLA, VEGF in 105 pheochromocytomas: enhanced expression correlates with malignant outcome. Apmis. ,vol. 111, pp. 458- 464 ,(2003) , 10.1034/J.1600-0463.2003.1110402.X
Frederieke M. Brouwers, Graeme Eisenhofer, Jessica J. Tao, Jeffrey A. Kant, Karen T. Adams, W. Marston Linehan, Karel Pacak, High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. The Journal of Clinical Endocrinology and Metabolism. ,vol. 91, pp. 4505- 4509 ,(2006) , 10.1210/JC.2006-0423
TAKAO NOSHIRO, HIDEMARU HONMA, KAZUMASA SHIMIZU, TAKU KUSAKARI, TOSHIYA WATANABE, HIROYOSHI AKAMA, SATORU SHIBUKAWA, WAKAKO MIURA, KEISHI ABE, YUKIO MIURA, Two Cases of Malignant Pheochromocytoma Treated with Cyclophosphamide,Vincristine and Dacarbazine in a combined Chemotherapy Endocrine Journal. ,vol. 43, pp. 279- 284 ,(1996) , 10.1507/ENDOCRJ.43.279
Carsten Boltze, Jochen Mundschenk, Nicole Unger, Regine Schneider-Stock, Brigitte Peters, Christian Mawrin, Cuong Hoang-Vu, Albert Roessner, Hendrik Lehnert, Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma. The Journal of Clinical Endocrinology and Metabolism. ,vol. 88, pp. 4280- 4286 ,(2003) , 10.1210/JC.2002-021299
Laurence Amar, Eric Baudin, Nelly Burnichon, Séverine Peyrard, Stéphane Silvera, Jérôme Bertherat, Xavier Bertagna, Martin Schlumberger, Xavier Jeunemaitre, Anne-Paule Gimenez-Roqueplo, Pierre-François Plouin, Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or Paragangliomas The Journal of Clinical Endocrinology and Metabolism. ,vol. 92, pp. 3822- 3828 ,(2007) , 10.1210/JC.2007-0709
Henri J. L. M. Timmers, Anna Kozupa, Graeme Eisenhofer, Margarita Raygada, Karen T. Adams, Daniel Solis, Jacques W. M. Lenders, Karel Pacak, Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. The Journal of Clinical Endocrinology and Metabolism. ,vol. 92, pp. 779- 786 ,(2007) , 10.1210/JC.2006-2315